| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | PHA-848125 |
|---|
| Description | PHA-848125 is a cyclin dependent kinase (CDK) inhibitor. Oral PHA-848125 showed antitumor activity via dual targeting of cyclin-dependent kinase and tropomyosin receptor kinase families in human carcinoma cell and xenografted mouse model of carcinoma. Molecular Formula: C25H32N8O Molecular Weight: 460.57 |
|---|
| Size | 2.5mg, 5mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 462344 |
|---|
| Price | |
|---|
| Order / More Info | PHA-848125 from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|